For older patients without an indication for pacing, the subcutaneous implantable cardioverter-defibrillator (S-ICD; Boston Scientific) provides results comparable to those seen with traditional ...
The randomized multicenter ATLAS trial of more than 500 persons has found that subcutaneous implantable cardioverter defibrillators (S-ICDs) reduce perioperative, lead-related complications without ...
Background For patients with a high risk of sudden cardiac death, despite the benefits of an implantable cardioverter ...
SAN FRANCISCO, CA—The subcutaneous implantable cardioverter-defibrillator (S-ICD; Boston Scientific) prevents most of the major lead-related complications seen with a transvenous system, the ATLAS ...
For patients getting a subcutaneous implantable cardioverter-defibrillator (S-ICD), routine defibrillation testing could be safely skipped when using a scoring system to evaluate device position and ...
AtaCor Medical, Inc., a privately-held medical device company focused on transforming cardiac rhythm management, announced today the enrollment of the first patient in the company's ALARION-EV study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results